The University of Glasgow’s MRC-Centre for Virus Research tests microwave systems for HPV treatment. Credit: University of Glasgow.

Researchers at the University of Glasgow in the UK are trialling a new microwave system for the treatment of pre-cancerous conditions caused by human papillomavirus (HPV).

Designed by Scotland-based firm Emblation, the system emits a low dose of energy to trigger an immune response. The portable device is reported to have been previously validated for the treatment of HPV-related verrucas.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

The latest study is intended to test the device’s efficacy in treating cervical precancerous cells and genital warts. Innovate UK is co-funding the research, which will be carried out at the university’s MRC-Centre for Virus Research.

“Researchers expect that the new system will provide a less invasive alternative for clearing HPV-infected living tissue, compared to existing painful and invasive treatments.”

MRC-Centre for Virus Research’s professor Shelia Graham said: “We plan to assess if the device can disrupt HPV and whether there is an effect on HPV-infected pre-cancerous and cancerous tissues.

“The project will validate the microwave device’s clinical potential but will also shed new light on how HPV-associated diseases arise.”

Researchers expect that the new system will provide a less invasive alternative for clearing HPV-infected living tissue, compared to existing painful and invasive treatments such as laser surgery.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Emblation’s research and development (R&D) director Dr Matt Kidd said: “This project is an exciting opportunity to further our knowledge and understanding of microwave interactions with diseased tissue.

“Our device has the potential to address the challenges associated with the treatment of precancerous conditions of the cervix, and the funding from Innovate UK has been crucial in allowing us to work with the experts at the University of Glasgow.”